Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass.
J Allergy Clin Immunol. 2019 Feb;143(2):782-785.e1. doi: 10.1016/j.jaci.2018.09.019. Epub 2018 Oct 9.
We demonstrate for the first time that EROS (CYBC1/C17ORF62) regulates abundance of the gp91phox-p22phox heterodimer of the phagocyte NADPH oxidase in human cells and that EROS mutations are a novel cause of chronic granulomatous disease.
我们首次证明,ERO(CYBC1/C17ORF62)在人细胞中调节吞噬细胞 NADPH 氧化酶的 gp91phox-p22phox 异二聚体的丰度,并且 EROS 突变是慢性肉芽肿病的一种新病因。